Clinical Trial Update: Efficacy and Safety of AQX-1125 in IC/BPS [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating AQX-1125 for Interstitial Cystitis/Bladder Pain Syndrome completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Pain Syndrome
• Interstitial Cystitis

Drugs mentioned

• AQX-1125

Snippet

Sponsor: Aquinox Pharmaceuticals (Canada) Inc. | Conditions: Interstitial Cystitis, Bladder Pain Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-09-05